Cell Technology Breakthrough

Early stem cell research has traditionally been associated with the controversial use of embryonic stem cells. The new focus is on non-embryonic adult mesenchymal stem cells which are found in a person’s own blood, bone marrow, and fat. Cell therapy around the world is shifting its focus from bone marrow based cells to adipose (fat) derived cells since the cells are easy to obtain and generally very robust. Adipose fat is an abundant and reliable source of stem cells. The best quality adipose cells are derived from the enzymatic digestion of liposuctioned fat which can be performed at the bedside in an essentially closed system to protect sterility. Autologous stem cells from a person’s own fat are easy to harvest safely under local anesthesia and are abundant in quantities up to 2500 times those seen in bone marrow.

The California Stem Cell Treatment Center cell harvesting and isolation techniques are based on technology from South Korea. Clinical success and favorable outcomes appear to be related directly to the quantity of stem cells deployed. This is a technological breakthrough as it allows patients to safely receive their own autologous stem cells in extremely large quantities. Once the adipose-derived stem cells are administered back to the patient, they have the potential to repair human tissue by influencing healing and also forming new cells of mesenchymal origin, such as cartilage, bone, ligaments, tendons, nerve, fat, muscle, blood vessels, and certain internal organs. Stem cells’ ability to form cartilage and bone makes them potentially highly effective in the treatment of degenerative orthopedic conditions. Their ability to form new blood vessels and other tissues makes them suitable for mitigating a large number of traumatic and degenerative conditions.

Over the past 10 years, we have collected clinical data from thousands of patients to determine safety and efficacy of every procedure we do for up to a 5 year period. This data, coupled with our direct work and partnerships with laboratories performing stem cell scientific research, has resulted in our advancement of the regenerative medical field, the advancement of personal cell therapy, and our 12 peer-reviewed publications covering safety, orthopedics, urology, neurology, and pain management. Our treatments and research are patient funded and we have endeavored successfully to make it affordable. All of our sterile procedures are non-invasive and done under local anesthesia. Patients who are looking for non-surgical alternatives to their degenerative disorders can participate in our trials by filling out our treatment application to determine if they are candidates.